New Delhi: India’s drug regulator has allowed The AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, News18 quoted Reuters as saying.
The approval, given to a licensed version of the drug made by the Serum Institute of India (SII) and exported to dozens of countries, could help health authorities to minimise vaccine wastage and better plan their inoculation programmes.
Some African countries have only until the middle of next month to use up more than a million doses of the vaccine branded Covishield by SII if the shelf life is not extended.
“You are permitted to apply the shelf-life of 9 months to unlabelled vials available on hand,” India’s drug controller-general, V.G. Somani, wrote late last month in reply to a request from the SII.
New Delhi: The Delhi Police on Thursday registered an FIR against Rahul Gandhi in connection with…
Mumbai: A video which went viral on social media shows Aishwarya Rai and the Bachchan…
New Delhi: The helicopter crash that killed India’s first Chief of Defence Staff (CDS) General…
Bhubaneswar: Around 1500 students who had passed out from different institutes of the Siksha ‘O’…
Mumbai: Rumours about Vijay Deverakonda dating Rashmika Mandanna has been doing the rounds for some…
New Delhi: BJP Members of Parliament (MPs) Pratap Sarangi and Mukesh Rajput, who were admitted…
This website uses cookies.